Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)-Reference-Cited by-同舟云学术

Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)

Published:2014-02-05 Issue:1 Volume:14 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Lindemann Kristina,Malander Susanne,Christensen Rene D,Mirza Mansoor R,Kristensen Gunnar B,Aavall-Lundqvist Elisabeth,Vergote Ignace,Rosenberg Per,Boman Karin,Nordstrøm Britta

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-14-68.pdf

Reference16 articles.

1. Parkin DM, Ferlay J, Curado MP, Bray F, Edwards B, Shin HR, Forman D: Fifty years of cancer incidence: CI5 I-IX. Int J Cancer J Int Du Cancer. 2010, 127 (12): 2918-2927. 10.1002/ijc.25517.

2. Lindemann K, Eskild A, Vatten LJ, Bray F: Endometrial cancer incidence trends in Norway during 1953-2007 and predictions for 2008-2027. Int J Cancer J Int Du Cancer. 2010, 127 (11): 2661-2668. 10.1002/ijc.25267.

3. Jongen V, Briet J, de Jong R, ten Hoor K, Boezen M, van der Zee A, Nijman H, Hollema H: Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and-B in a large cohort of patients with endometrioid endometrial cancer. Gynecol Oncol. 2009, 112 (3): 537-542. 10.1016/j.ygyno.2008.10.032.

4. Decruze SB, Green JA: Hormone therapy in advanced and recurrent endometrial cancer: a systematic review. Int J Gynecol Cancer. 2007, 17 (5): 964-978. 10.1111/j.1525-1438.2007.00897.x.

5. Singh M, Zaino RJ, Filiaci VJ, Leslie KK: Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a gynecologic oncology group study. Gynecol Oncol. 2007, 106 (2): 325-333. 10.1016/j.ygyno.2007.03.042.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Redefining the Position of Hormonal Therapy in Endometrial Cancer in the Era of Molecular Classification;Journal of Clinical Oncology;2024-01-01

2. Do Not Forget about Hormonal Therapy for Recurrent Endometrial Cancer: A Review of Options, Updates, and New Combinations;Cancers;2023-03-16

3. The effect of progestin therapy in advanced and recurrent endometrial cancer: A systematic review and meta‐analysis;BJOG: An International Journal of Obstetrics & Gynaecology;2022-11-13

4. Endometrial cancer;The Lancet;2022-04

5. Recurrent Endometrial Cancer: Local and Systemic Treatment Options;Cancers;2021-12-14